Nutritional, Pharmacological and Medicinal Properties of Momordica Charantia
Open Access
- 10 February 2015
- journal article
- Published by Science Publishing Group in International Journal of Nutrition and Food Sciences
- Vol. 4 (1) , 75-83
Abstract
Momordica charantia L. (Bitter gourd) is a flowering vine in the family of Cucurbitaceae. It contains an array of novel and biologically active phytochemicals including triterpenes, proteins and steroids. Medicinally, the plant has a long history of use by the indigenous people as a folk medicine. Bitter gourd is often used in Chinese cooking for its bitter flavor, typically in stir-fries, soups, and also as tea. Pakistan, Philippines, Panama and Nepal also use this bitter vegetable for culinary purposes in addition to India. Several medicinal properties of the bitter gourd have been studied by various researchers, such as anti-diabetic, anti-ulcerogenic, anti-mutagenic, antioxidant, anti-tumour, anti-lipolytic, analgesic, abortifacient, anti-viral, hypoglycemic and immunomodulatory. In vitro studies reveals that the bitter gourd proteins (α-and β-monorcharin) have inhibitory effect against HIV virus, and leaf extracts have broad-spectrum anti-microbial activity as well. Many in vivo studies have demonstrated the relatively low toxicity of all parts of the bitter gourd plant when ingested orally. This review also addresses taxonomy, phytochemical, culinary practices and pharmacological properties in detail. Over the years scientists have verified many of the traditional uses of this bitter plant that continues to be an important natural remedy in herbal medicine systems. Bitter gourd products such as concentrated fruit and seed extracts can be found in capsules and tablets, as well as in whole herb/vine powder forms and these supplements are becoming more widely available in many countries nowadays as prophylactic or therapeutic agents.Keywords
This publication has 43 references indexed in Scilit:
- Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic miceFood and Chemical Toxicology, 2014
- Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantiaFitoterapia, 2014
- The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivoCancer Letters, 2012
- Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitroFood Chemistry, 2008
- A new cucurbitane triterpenoid from Momordica charantiaChinese Chemical Letters, 2007
- Dietary Effects of Bitter Gourd Oil on Blood and Liver Lipids of RatsArchives of Biochemistry and Biophysics, 2001
- Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extractJournal of Biochemical and Molecular Toxicology, 2000
- Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melonGene, 1995
- Crystal structure of momordin, a type I Ribosome Inactivating Protein from the seeds of Momordica charantiaFEBS Letters, 1994
- The immunomodulatory activity of the plant proteins Momordica Charantia inhibitor and Pokeweed antiviral proteinInternational Journal of Immunopharmacology, 1983